Latest News
The mostly forgotten former technology titan may quietly be sitting on the next big thing in AI's ongoing evolution.
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
If CAP-1002 (Deramiocel) is approved on schedule, deramiocel would become the first therapy indicated specifically for DMD-associated cardiomyopathy, addressing a critical unmet need. The StealthX(tm) exosome delivery system is a momentous change.
Via Talk Markets · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
Via Benzinga · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
The weekend saw major developments in the cryptocurrency world, including Ripple's concerns over the UK's crypto regulations, Circle's plans for a $5 billion IPO, Anthony Pompliano's praise for Trump's tariffs as a catalyst for crypto, and expectations of a Bitcoin price surge following potential monetary easing by the Fed.
Via Benzinga · April 6, 2025
Via The Motley Fool · April 6, 2025
Via The Motley Fool · April 6, 2025
Thursday and Friday saw gold, itself overdue to come off, finally so do while stocks got boffed and silver summarily slaughtereds.
Via Talk Markets · April 6, 2025
Via The Motley Fool · April 6, 2025
Let’s not sugarcoat it — last week was straight-up financial mayhem. If you thought we were already deep in the woods, markets handed us a map, lit it on fire, and said, “Good luck.”
Via Talk Markets · April 6, 2025